Symbol="KNTE"
AssetType="Common Stock"
Name="Kinnate BiopharmaÂ Inc"
Description="Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. The company is headquartered in San Diego, California."
CIK="1797768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11975 EL CAMINO REAL, STE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="146937000"
EBITDA="-125366000"
PERatio="None"
PEGRatio="None"
BookValue="4.783"
DividendPerShare="0"
DividendYield="0"
EPS="-2.72"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-0.442"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="21.06"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.063"
EVToRevenue="-"
EVToEBITDA="-0.336"
Beta="-0.0208"
num_52WeekHigh="15.86"
num_52WeekLow="2.32"
num_50DayMovingAverage="3.52"
num_200DayMovingAverage="5.81"
SharesOutstanding="46572600"
DividendDate="None"
ExDividendDate="None"
symbol="KNTE"
open="3.23"
high="3.25"
low="2.95"
price="2.96"
volume="157324.00"
latest_trading_day="2023-07-24"
previous_close="3.21"
change="-0.25"
change_percent="-7.7882%"
aroon_positive_momentum_days="6"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="412589"
Change_recent_avg="-0.04"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-1.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="1130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0163.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="973"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_positive_thumbnail_id_2="700"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
